Clinical experience with depot neuroleptics.

Clinical experience with depot neuroleptics. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Clinical experience with depot neuroleptics. Abstract Text:

O Bakke,

Clinical experience with depot neuroleptics. Publishing Authors By Initials

O Bakke,

For similar chemical actions and uses: pharmacologic actions: physiological effects of drugs: central nervous system depressants: tranquilizing agents research abstracts see: chemical actions and uses: pharmacologic actions: physiological effects of drugs: central nervous system depressants: tranquilizing agents research

PUBMED ID PMID:

MEDLINE DATE:

Clinical experience with depot neuroleptics. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Acta psychiatrica Scandinavica. Supplementum

VOLUME: 246

Page Numbers: 32-4

Journal Abbreviation:

ISSN: 0065-1591

DAY: 15

MONTH: 02

YEAR: 1973

Clinical experience with depot neuroleptics. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370365

Clinical experience with depot neuroleptics. Keywords Mesh Terms:

KEYWORDS: Tranquilizing Agents

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Clinical experience with depot neuroleptics. Information

Substance Name: Fluphenazine

Registry Number: 69-23-8

Grant and Affiliation Information for Clinical experience with depot neuroleptics.

AFFILIATION:

Country: DENMARK

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Acta Psychiatr Scand Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Clinical experience with depot neuroleptics Related Publications

• Alterations in T-cell subset frequency in peripheral blood in obesity.
• Cell-cycle-dependent binding kinetics for the early endosomal tethering factor EEA1.
• Children, resilience and disasters: recent evidence that should influence a model of psychosocial care.
• Clinical experience with depot neuroleptics.
• Does smoking affect the outcome of patient education and self-management in asthmatics?
• Factors affecting growth of FEV1.
• Host-based identification is not supported by morphometrics in natural populations of Gyrodactylus salaris and G. thymalli (Platyhelminthes, Monogenea).
• Human PARM-1 is a novel mucin-like, androgen-regulated gene exhibiting proliferative effects in prostate cancer cells.
• No increase in response rate by adding a web response option to a postal population survey: a randomized trial.
• Phosphorylation of steroidogenic factor 1 is mediated by cyclin-dependent kinase 7.
• Respiratory symptoms, COPD severity, and health related quality of life in a general population sample.
• ["Phenacetin-kidney" or "analgetic-nephropathy"]
• [2 simple diagnostic procedures in stress incontinence in women]
• [Breakdown of organic nitrates in liver. Few arguments against oral administration of nitro compounds in angina pectoris]
• [Choice of analgesic in myocardial infarct]
• [Dangerous and useless drugs in Spain and in other Mediterranean countries]
• [Data technics in information systems. Promises and threats]
• [Extra-uterine pregnancy with intra-uterine prevention]
• [Follow up of urinary tract problems in adults with myelomeningocele]
• [Hallucinations in diphenhydramine poisoning]
• [In Process Citation]
• [Neuroradiological imaging of the 3rd, 4th and 6th cranial nerves]
• [Nonpuerperal chronic inversion of the uterus]
• [Periarthritis calcarea carpi]
• [Prolonged pregnancy--selection of pregnant women for induced labor]
• [Terror against the free world--politics and the Norwegian Medical Society]
• [The effect of patient education in asthma, a randomized controlled trial]
• [Time of crisis is time of possibilities--securing the recruitment with the help of the listed patients' system]
• [Usefulness of SPECT and MRI in the diagnosis of atypical parkinsonism]
• [Voiding problems and urinary tract complications in adolescents and adults with myelomeningocele]